AstraZeneca explores $400 billion tie-up with Bristol Myers
What's at stake: A deal would create one of the world's biggest drugmakers, though talks could still stall or collapse.
The Straits Times, The Business Times (Singapore)
Subject
What's at stake: A deal would create one of the world's biggest drugmakers, though talks could still stall or collapse.